SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-19-002131
Filing Date
2019-02-12
Accepted
2019-02-11 19:26:58
Documents
3
Period of Report
2019-02-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k021119_elitepharma.htm 8-K 24793
2 PRESS RELEASE DATED FEBRUARY 11, 2019 f8k021119ex99-1_elitepharma.htm EX-99.1 14056
3 GRAPHIC ex99-1_001.jpg GRAPHIC 8052
  Complete submission text file 0001213900-19-002131.txt   51323
Mailing Address 165 LUDLOW AVENUE NORTHVALE NJ 07647
Business Address 165 LUDLOW AVENUE NORTHVALE NJ 07647 2017502646
ELITE PHARMACEUTICALS INC /NV/ (Filer) CIK: 0001053369 (see all company filings)

IRS No.: 223542636 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-15697 | Film No.: 19587173
SIC: 2834 Pharmaceutical Preparations